David Powell (
Abby Alpert is an assistant professor at the Wharton School, University of Pennsylvania, in Philadelphia.
Health Aff (Millwood). 2019 Feb;38(2):287-294. doi: 10.1377/hlthaff.2018.05232.
The hepatitis C virus is responsible for more deaths in the United States than any other infectious disease, and hepatitis C infections have been rising at an alarming rate since 2010. We evaluated the role of the opioid epidemic and, in particular, the 2010 introduction of an abuse-deterrent version of OxyContin. The OxyContin reformulation led some users of the drug to switch to heroin, which could have exposed them to the hepatitis C virus. We used difference-in-differences methods, using data for the period 2004-15, to assess whether states with higher rates of OxyContin misuse prior to reformulation-states where the reformulation had more impact-experienced faster growth in infections after the reformulation. States with above-median OxyContin misuse before the reformulation experienced a 222 percent increase in hepatitis C infection rates in the post-reformulation period, while states with below-median misuse experienced only a 75 percent increase. These results suggest that interventions to deter opioid misuse can have unintended long-term public health consequences.
丙型肝炎病毒是美国导致死亡人数超过其他任何传染病的罪魁祸首,自 2010 年以来,丙型肝炎感染率以惊人的速度上升。我们评估了阿片类药物泛滥的作用,特别是 2010 年引入了一种具有滥用抑制特性的奥施康定版本。奥施康定的配方改革促使一些药物使用者转而使用海洛因,这可能使他们接触到丙型肝炎病毒。我们使用差分法,利用 2004-15 年的数据,评估在配方改革之前滥用奥施康定率较高的州(即改革影响较大的州)在配方改革后的感染率增长速度是否更快。在配方改革之前,奥施康定滥用率高于中位数的州在配方改革后的丙型肝炎感染率增长了 222%,而滥用率低于中位数的州仅增长了 75%。这些结果表明,抑制阿片类药物滥用的干预措施可能会产生意想不到的长期公共卫生后果。